Back
Perspective Therapeutics Stock Predictions
![](/images/offers/ims/large/offer9.jpg)
The #1 free indicator I've used for 30 years
The indicator is free... and the 23-page book I wrote for you is also free.
Sell
30
CATX
Perspective Therapeutics
Last Price:
9.88
Seasonality Move:
3.69%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer13.jpg)
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.Perspective Therapeutics Stock Forecast
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 28% based on the past 20 years of stock performance.
- Perspective Therapeutics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Perspective Therapeutics Stock Undervalued?
The current Perspective Therapeutics [CATX] share price is $9.51. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal. - CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 28% based on the past 20 years of stock performance.
Perspective Therapeutics Stock Rating
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics overpriced?
- Perspective Therapeutics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Perspective Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
19.05
52-Week Low:
2.05
Prediction Charts
Market Cap:
641.11M
Price in USD:
9.51
Volume:
1.99M
Beta:
1.36
Technical Analysis
SMA50:
14.61
SMA100:
12.86
SMA200:
8.17
52-Wk Change:
43.01%
Stock Predictions
-
Is Perspective Therapeutics stock public?
Yes, Perspective Therapeutics is a publicly traded company. -
What is the Perspective Therapeutics stock quote today?
The Perspective Therapeutics stock price is 9.51 USD today. -
How to buy Perspective Therapeutics stock online?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-6 | 13.90 | 12.90 | 14.00 | 12.60 |
Jun-7 | 12.90 | 12.00 | 13.26 | 11.90 |
Jun-10 | 11.40 | 13.00 | 13.20 | 10.20 |
Jun-11 | 12.50 | 12.60 | 12.90 | 11.30 |
Jun-12 | 12.80 | 13.30 | 13.60 | 12.52 |
Jun-13 | 13.60 | 11.60 | 13.60 | 11.60 |
Jun-14 | 12.90 | 10.70 | 12.90 | 10.50 |
Jun-17 | 10.40 | 10.34 | 10.65 | 9.61 |
Jun-18 | 10.68 | 11.93 | 11.93 | 10.00 |
Jun-20 | 12.01 | 10.65 | 12.45 | 10.45 |
Jun-21 | 10.48 | 10.09 | 10.60 | 9.95 |
Jun-24 | 10.01 | 10.30 | 10.76 | 9.95 |
Jun-25 | 10.20 | 9.55 | 10.27 | 9.36 |
Jun-26 | 9.33 | 9.51 | 9.64 | 8.16 |
Perspective Therapeutics Earnings
Perspective Therapeutics Earnings Report: Per Share Perspective Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Perspective Therapeutics Forecast Revenue Growth
Perspective Therapeutics Stock Analysis: Historical quarterly revenues per share for Perspective Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.